<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68646">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01683240</url>
  </required_header>
  <id_info>
    <org_study_id>Short Access Cholangioscope</org_study_id>
    <secondary_id>PV 3526</secondary_id>
    <nct_id>NCT01683240</nct_id>
  </id_info>
  <brief_title>Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones</brief_title>
  <acronym>SAC</acronym>
  <official_title>Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KARL STORZ GmbH &amp; Co. KG, Tuttlingen, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Karl Storz GmbH (Gesellschaft mit beschränkter Haftung) company developed a cholangioscopic
      device, which is designed to give a better flexibility to the cholangioscopy tip in order to
      enable optimal diagnostic and therapeutic precondition. Other than the conventional
      mother-baby technique, the insertion of the cholangioscope (baby part) is done by a port at
      the side of a specially developed duodenoscope (mother part)which is prepositioned distally
      to the control unit, near to the patient's mouth. Better manoeuverability of the device tip
      will lead to both a better accuracy in taking biopsies as well as a better flexibility in
      lithotripsy manoeuvres. This study is designed to test the efficiency of the device in
      relation to this assumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cholangioscopy is a subsidiary treatment in endoscopic retrograde cholangiopancreaticography
      (ERCP), used for special issues. In the context of ERCP, a long,thin shaped device is
      introduced through the working channel of a duodenoscope and then through the papilla into
      the biliary duct.

      Inspection of the biliary duct can be used for tumor biopsies as well as for gall stone
      lithotripsy by laser or electrohydraulic technique.

      Manoeuverability of cholangioscopes is limited by the length of the scope, even more, since
      most of the device body is stuck in the working channel.

      The newly designed cholangioscope by the company of Karl Storz GmbH is introduced through a
      shortened working channel. Introduction of the cholangioscope is done by an innovative side
      port for the cholangioscope at 70 cm from the insertion tube's distal end. This leads to a
      better flexibility of the device tip. Better manoeuverability of the device tip will lead to
      both a better accuracy in taking biopsies as well as a better flexibility in lithotripsy
      manoeuvres.

      This study is designed to test the efficiency of the device in relation to this assumption.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Efficacy of cholangioscopy in gallstone therapy and stricture diagnosis</measure>
    <time_frame>Patients will be monitored during stay in hospital, average stay is 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>complete lithotripsy in a single session
rate of right positive malignoma diagnostics (sensitivity)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>while examination and 24 hrs past examination</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of complications during examination and during monitoring over 24 hours post procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallstone therapy</measure>
    <time_frame>procedure, average procedure time 1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time of procedure and success of stone extraction in %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stricture diagnostic</measure>
    <time_frame>procedure, average procedure time is 1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of biopsies taken. Evaluation of quality of biopsies by pathologists (pathological department of University Hospital Hamburg Eppendorf).
Minimum number of bioptic manoeuvres: 3 Comparison with brush cytology (3 brush manoeuvres with 12 smear preparations) by reference cytologist (Dr. Topalidis, Hannover)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Choledocholithiasis</condition>
  <condition>Common Bile Duct Neoplasms</condition>
  <condition>Cholestasis</condition>
  <arm_group>
    <arm_group_label>Frimberger cholangioscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with need for cholangioscopy due to gallstones or histological evaluation of strictures</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cholangioscopy (Frimberger)</intervention_name>
    <description>cholangioscopy with Frimberger duodenoscope system by the company of Karl Storz GmbH</description>
    <arm_group_label>Frimberger cholangioscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Choledocholithiasis, not treatable through conventional ERCP with sphincterotomy.

          -  Stricture of the biliary duct in need of histopathological investigation

        Exclusion Criteria:

          -  Aggravated or impossible access to papilla

          -  Inappropriate biliary anatomy, e.g. multiple strictures or diameter of duct &lt;
             cholangioscope impairing intubation

          -  Primary sclerosing cholangitis

          -  Coagulopathy (quick &lt; 50%, thrombocytes &lt; 50/nl)and anticoagulant medication

          -  Bad patient's condition (ASA IV)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Rösch, Prof. Dr.</last_name>
    <phone>+49 40 7410</phone>
    <phone_ext>50098</phone_ext>
    <email>t.roesch@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrike W Denzer, PD DR.</last_name>
    <phone>+49 40 7410</phone>
    <phone_ext>55380</phone_ext>
    <email>u.denzer@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité Universitätsmedizin, Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Veltzke-Schlieker, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>A. Adler, Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>W. Veltzke-Schlieker, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>A. Adler, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Rösch, Prof. Dr.</last_name>
      <phone>+49 40 7410</phone>
      <phone_ext>50098</phone_ext>
      <email>t.roesch@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike W Denzer, PD Dr.</last_name>
      <phone>+49 40 7410</phone>
      <phone_ext>55380</phone_ext>
      <email>u.denzer@uke.de</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Rösch, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrike W Denzer, PD Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guido Schachschal, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Hamburg Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Friedrich Hagenmüller, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Friedrich Hagenmüller, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Hamburg Barmbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22291</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Siegbert Faiss, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Siegbert Faiss, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Israelitisches Krankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22297</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ulrich Rosien, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Ulrich Rosien, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Pomerantz BJ. Biliary tract interventions. Tech Vasc Interv Radiol. 2009 Jun;12(2):162-70. Review.</citation>
    <PMID>19853234</PMID>
  </reference>
  <reference>
    <citation>Tsuyuguchi T, Fukuda Y, Saisho H. Peroral cholangioscopy for the diagnosis and treatment of biliary diseases. J Hepatobiliary Pancreat Surg. 2006;13(2):94-9. Review.</citation>
    <PMID>16547668</PMID>
  </reference>
  <reference>
    <citation>Ross AS, Kozarek RA. Cholangioscopy: where are we now? Curr Opin Gastroenterol. 2009 May;25(3):245-51. Review.</citation>
    <PMID>19381085</PMID>
  </reference>
  <reference>
    <citation>Darcy M, Picus D. Cholangioscopy. Tech Vasc Interv Radiol. 2008 Jun;11(2):133-42. Review.</citation>
    <PMID>18922458</PMID>
  </reference>
  <reference>
    <citation>Small AJ, Baron TH. Novel endoscopic approaches for assessing biliary tract diseases. Curr Opin Gastroenterol. 2008 May;24(3):357-62. Review.</citation>
    <PMID>18408465</PMID>
  </reference>
  <reference>
    <citation>Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005 Sep;62(3):374-82.</citation>
    <PMID>16111955</PMID>
  </reference>
  <reference>
    <citation>Kim HJ, Kim MH, Lee SK, Yoo KS, Seo DW, Min YI. Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture. Gastrointest Endosc. 2000 Nov;52(5):635-8.</citation>
    <PMID>11060188</PMID>
  </reference>
  <reference>
    <citation>Nimura Y, Kamiya J, Hayakawa N, Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps. Endoscopy. 1989 Dec;21 Suppl 1:351-6.</citation>
    <PMID>2606085</PMID>
  </reference>
  <reference>
    <citation>Seo DW, Lee SK, Yoo KS, Kang GH, Kim MH, Suh DJ, Min YI. Cholangioscopic findings in bile duct tumors. Gastrointest Endosc. 2000 Nov;52(5):630-4.</citation>
    <PMID>11060187</PMID>
  </reference>
  <reference>
    <citation>Tamada K, Ueno N, Tomiyama T, Oohashi A, Wada S, Nishizono T, Tano S, Aizawa T, Ido K, Kimura K. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc. 1998 May;47(5):341-9.</citation>
    <PMID>9609424</PMID>
  </reference>
  <reference>
    <citation>Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Moriyasu F, Gotoda T. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc. 2007 Oct;66(4):730-6.</citation>
    <PMID>17905015</PMID>
  </reference>
  <reference>
    <citation>Hoffman A, Kiesslich R, Bittinger F, Galle PR, Neurath MF. Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. Endoscopy. 2008 Jul;40(7):563-71. Epub 2008 Apr 11.</citation>
    <PMID>18404601</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>July 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cholangiography</keyword>
  <keyword>cholangioscopy</keyword>
  <keyword>mother-baby</keyword>
  <keyword>cholangioscope</keyword>
  <keyword>Frimberger cholangioscope</keyword>
  <keyword>short access cholangioscopy</keyword>
  <keyword>ERCP</keyword>
  <keyword>gallstone therapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bile Duct Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Common Bile Duct Neoplasms</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
